Kahnert, Kathrin
Alter, Peter
Welte, Tobias
Huber, Rudolf M.
Behr, Jürgen
Biertz, Frank
Watz, Henrik
Bals, Robert
Vogelmeier, Claus F.
Jörres, Rudolf A.
Funding for this research was provided by:
German Federal Ministry of Education and Research (01 GI 0881)
Competence Network Asthma and COPD
German Centre for Lung Research
AstraZeneca GmbH
Bayer Schering Pharma AG
Boehringer Ingelheim Pharma GmbH & Co. KG
Chiesi GmbH
GlaxoSmithKline
Grifols Deutschland GmbH
MSD Sharp & Dohme GmbH
Mundipharma GmbH
Novartis Pharma
Pfizer Pharma GmbH
Takeda Pharma Vertrieb GmbH & Co. KG
Article History
Received: 20 February 2018
Accepted: 20 May 2018
First Online: 4 June 2018
Ethics approval and consent to participate
: All assessments were approved by the central (Marburg (Ethikkommission FB Medizin Marburg) and local (Bad Reichenhall (Ethikkommission bayerische Landesärztekammer); Berlin (Ethikkommission Ärztekammer Berlin); Bochum (Ethikkommission Medizinische Fakultät der RUB); Borstel (Ethikkommission Universität Lübeck); Coswig (Ethikkommission TU Dresden); Donaustauf (Ethikkommission Universitätsklinikum Regensburg); Essen (Ethikkommission Medizinische Fakultät Duisburg-Essen); Gießen (Ethikkommission Fachbereich Medizin); Greifswald (Ethikkommission Universitätsmedizin Greifswald); Großhansdorf (Ethikkommission Ärztekammer Schleswig-Holstein); Hamburg (Ethikkommission Ärztekammer Hamburg); MHH Hannover/Coppenbrügge (MHH Ethikkommission); Heidelberg Thorax/Uniklinik (Ethikkommission Universität Heidelberg); Homburg (Ethikkommission Saarbrücken); Immenhausen (Ethikkommission Landesärztekammer Hessen); Kiel (Ethikkommission Christian-Albrechts-Universität zu Kiel); Leipzig (Ethikkommission Universität Leipzig); Löwenstein (Ethikkommission Landesärztekammer Baden-Württemberg); Mainz (Ethikkommission Landesärztekammer Rheinland-Pfalz); München LMU/Gauting (Ethikkommission Klinikum Universität München); Nürnberg (Ethikkommission Friedrich-Alexander-Universität Erlangen Nürnberg); Rostock (Ethikkommission Universität Rostock); Berchtesgadener Land (Ethikkommission Land Salzburg); Schmallenberg (Ethikkommission Ärztekammer Westfalen-Lippe); Solingen (Ethikkommission Universität Witten-Herdecke); Ulm (Ethikkommission Universität Ulm); Würzburg (Ethikkommission Universität Würzburg)) ethical committees and written informed consent was obtained from all patients.The study was conducted from September 2011 to December 2013 and comprised 151 patients recruited within the COSYCONET framework (, Identifier: NCT01245933).For further information see: Karch A, Vogelmeier C, Welte T, Bals R, Kauczor HU, Biederer J, Heinrich J, Schulz H, Glaser S, Holle R et al.: The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. Respir Med 2016, 114:27–37.
: All COSYCONET participants gave their written informed consent in which the patients also agreed to the scientific evaluation and publication of the collected data.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.